Myeloproliferative disorders include several different conditions that are characterized by excess production of blood cells ...

Veliparib ER is under clinical development by AbbVie and currently in Phase II for Myeloproliferative Disorders.

The individual behavior of a patient’s myeloproliferative neoplasm (MPN) will determine how the disease is monitored and ...

One of the things he mentioned was the disease’s transition from a myeloproliferative disorder to a myeloproliferative ...

HMPL-306 is under clinical development by Hutchison MediPharma and currently in Phase I for Myeloproliferative Disorders.

There’s a balance required to manage both the symptoms of myelofibrosis through treatment and the side effects caused by the ...

Polycythemia vera and essential thrombocythemia are the most common chronic myeloproliferative neoplasms ... are pushing therapeutic goals from disease control only to cure.

While in nursing school, a patient recognized potential signs of a blood disorder and advocated for further testing, leading ...

A young Monroe County girl got her biggest Christmas wish this year as a friend of her family went out of his way to design ...

Dr. Rachel Salit is a hematologist and oncologist, and member of the stem cell transplant faculty at Fred Hutch who focuses on improving stem cell transplant outcomes for patients who have ...